Edoardo Cignoli : Deal Flurry Shows Drug Makers' Swing Toward Specialization

After decades of broadening their drug portfolios through acquisitions, pharmaceutical companies are reversing course to focus more narrowly on what they think they can do best.



via WSJ.com: US Business http://ift.tt/1mBXY6e